Editorial Policy

Last updated: April 14, 2026

1. Purpose and scope

CareBareRX publishes educational content for readers researching GLP-1 pathways, online program quality, and out-of-pocket planning. Content is informational and does not replace medical advice.

2. Authorship and accountability

Articles are written and maintained by the following editorial profile(s):

• CareBareRX Editorial Team - Health Content Team. Affiliate-health writers focused on GLP-1 patient education, evidence summaries, and consumer decision frameworks.

3. Source standards

We prioritize sources in this order:

• Peer-reviewed clinical studies and systematic reviews
• FDA/NIH/NIDDK and other high-trust public health sources
• High-trust policy and cost-access reporting (for affordability context)
• Regulatory and advertising compliance guidance

Every article includes a citation list and in-section source references so readers can trace claims directly to source materials.

4. Claim style and limitations

• No guaranteed-outcome claims
• No claims that imply CareBareRX provides medical diagnosis or treatment
• Clear disclosure that prescribing decisions are made by independent licensed providers

5. Update and review cadence

Each article includes an evidence review date. We review high-impact pages on a recurring basis and update content when new evidence, safety guidance, or policy changes materially affect reader decisions.

6. Corrections policy

If a factual error is identified, we update the article promptly and revise timestamps as needed. For correction requests, contact info@carebarerx.com.